By Marcus Devlin
Two decades covering equity markets. Writes on single stocks, sectors, valuations and the trades behind the tape.
Dynatrace beats Q1 estimates as AI customers drive higher platform usage
Dynatrace reported better-than-expected fiscal Q1 results, with annual recurring revenue up 17% on a constant-currency basis. RBC says custo
RBC Holds Angi Rating at Sector Perform, Cuts Forecasts After Soft Q2
RBC maintained its sector perform rating and $5 price target on Angi after the company's Q2 results came in softer than expected. The bank c
Alkami launches sale process after Jana builds 5.1% stake
Alkami Technology has kicked off a sale process, with advisers contacting private equity firms after activist Jana Partners built a 5.1% sta
Swiss stocks end winning streak as Swisscom jumps 4.4% on dividend outlook
Swiss stocks slipped, snapping a three-day winning streak, even as telecom giant Swisscom jumped 4.38% after reaffirming its 2026 guidance a
Deutsche Telekom surges on higher cash outlook; Siemens slips despite beat
Germany's DAX edged up 0.15% as Deutsche Telekom jumped 6.31% on a raised cash outlook and bigger buyback plan, while Siemens fell 4.56% des
FTSE 100 slips as Iran-Oman shipping plan eases Hormuz fears
The FTSE 100 slipped as Iran and Oman outlined a temporary shipping route through the Strait of Hormuz, easing some supply fears. Housebuild
Onterris downgraded by BofA as 2026 outlook weakens, strategic review begins
Bank of America downgraded Onterris to underperform and cut its price target to $18 from $31 after the company lowered 2026 EBITDA guidance
CDW's Q2 beat overshadowed by margin worries, Morgan Stanley says
CDW delivered a strong second quarter, but investors zeroed in on softer gross margins. Morgan Stanley argues the market is overreacting, no
Musk's SpaceX and Tesla unveil $16.8B Texas AI chip 'Terafab'
SpaceX and Tesla plan to spend $16.8 billion on a massive AI chip facility in Texas, aiming to secure supply for robotics and space systems.
Asia ADRs edge up as Zai Lab surges 12.8%, Jiayin drops 12%
The S&P Asia 50 ADR Index rose 0.55% in early US trading, but the real moves were in individual stocks: Zai Lab surged 12.8% while Jiayin Gr
Ralph Lauren beats estimates on Asia boom, but forecast disappoints
Ralph Lauren topped quarterly expectations thanks to a 24% surge in Asia sales, but its annual forecast disappointed. The company raised its
Tarsus to buy Alkeus for up to $800M, adding Stargardt disease drug
Tarsus Pharmaceuticals is buying Alkeus for up to $800 million, adding a late-stage treatment for Stargardt disease, a rare inherited retina